I help pharmaceutical launch teams align cross-functional messaging before regulatory review so they avoid delays that cost $10-50M per month.
Proven methodology from 15+ years at Johnson & Johnson, McCann Health, and leading pharmaceutical agencies.
Most pharmaceutical product launches face costly delays because brand, medical affairs, legal, and regulatory departments can’t align on messaging.
By the time misalignment is discovered, during regulatory review or worse, after launch, it’s too late.
The result:
There’s a better way.
Makeni Bent Digital Consulting hosts messaging alignment workshops across internal teams to surface blockers and maintain compliance before regulatory reviews.
ROI: If this workshop prevents even a 1-week launch delay, you’ve achieved a 1,600X return on investment.
Who i work with
This workshop is designed for:
Companies with multiple simultaneous launches benefit from portfolio-level alignment packages.
Co-led content migration strategy for seven MedTech companies into unified jnjmedtech.com platform. Managed cross-functional coordination across brand, medical affairs, legal, and regulatory.
Agency-side pharmaceutical marketing spanning Novartis, Bristol Myers Squibb, Pfizer, and other global pharmaceutical clients. Navigated complex compliance-driven messaging and stakeholder alignment.
St. John's University
Don’t just take our word for it. Here’s what some of our satisfied clients have to say about our financial solutions.
Reach out to us to book a consultation.